Fred Ramsdell
Gründer bei Sonoma Biotherapeutics, Inc.
Profil
Fred Ramsdell is the founder of Sonoma Biotherapeutics, Inc. founded in 2019, where he holds the title of Chief Scientific Officer.
In 2014-2016, he worked as Vice President-Immunology at aTyr Pharma, Inc. Dr. Ramsdell holds a doctorate from the University of California, Los Angeles and an undergraduate degree from the University of California San Diego.
Aktive Positionen von Fred Ramsdell
Unternehmen | Position | Beginn |
---|---|---|
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA. | Gründer | 01.01.2019 |
Ehemalige bekannte Positionen von Fred Ramsdell
Unternehmen | Position | Ende |
---|---|---|
ATYR PHARMA, INC. | Corporate Officer/Principal | 01.12.2016 |
Ausbildung von Fred Ramsdell
University of California, Los Angeles | Doctorate Degree |
University of California San Diego | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ATYR PHARMA, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA. | Health Technology |